Author:
Kusunoki Nobuya,Ku Yonson,Tominaga Masahiro,Iwasaki Takeshi,Fukumoto Takumi,Muramatsu Sanshiro,Sugimoto Takemi,Tsuchida Shinobu,Takamatsu Manabu,Suzuki Yasuyuki,Kuroda Yoshikazu
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Calvo DB, Patt YZ, Wallace S, et al. Phase I-II trial of percutaneous intra-arterial cis-diamminedichloro platinum (II) for regionally confined malignancy. Cancer 1980; 45: 1278?83.
2. Campbell TN, Howell SB, Pfeifle CE, Wung WE, Bookstein J. Clinical pharmacokinetics of intraarterial cisplatin in humans. J Clin Oncol 1983; 1: 755?62.
3. Vexler AM, Mou X, Gabizon AA, Gorodetsky R. Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies. Int J Cancer 1995; 60: 611?5.
4. Civalleri D, Esposito M, Fulco RA, et al. Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases. Cancer 1991; 68: 988?94.
5. KuY, Samizo M, Fukumoto T, et al. Comparison of hepatic tissue extraction rates of cytotoxic anticancer drugs during hepatic arterial chemotherapy: evaluation using direct hemoperfusion under hepatic venous isolation [in Japanese with English abstract]. Jpn J Gastroenterol 1993; 90: 41?8.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献